A shocking NHS-supported trial has now been suspended following officials’ warnings of “significant” long-term harms to young people. The controversial plans aimed to give puberty blockers to children as young as eight-years-old, but the UK’s medicines regulator has finally stepped in to stop it, citing major safety fears.

TRUTH LIVES on athttps://sgtreport.tv/

The trial was originally announced inNovember 2025, in which the NHS planned to prescribe banned puberty blockers to more than 200 young people – targeting kids as young as eight – who thought they may be transgender. At the time, parents nationwide called it a “betrayal of children”, and protests quickly assembled.

The original plan was to fund the trial with approximately £11 million ($15 million) of taxpayers’ money, which would go on for several years. In the streets and in Parliament, critics immediately raised concerns about the danger of the experiment because it involved giving powerful hormone-suppressing drugs to physically healthy children without robust long-term evidence of safety or benefit. They argued it could permanently affect bone, brain and reproductive development.

It all stems from recommendations in the 2024Cass review, which itself found that the evidence supporting puberty blockers in gender-questioning young people is very weak. Several MPs and clinicians had warned that this weak scientific foundation should not justify exposing children to potentially irreversible treatments. Baroness Hilary Cass, who led the review, reiterated the weak evidence base, but said “given that there are clinicians, children and families who believe passionately in the beneficial effects, a trial was the only way forward to make sense of this”.

At the time, political unease was clear. Health Secretary Wes Streeting expressed his discomfort with the idea of giving puberty blockers to children, but said he was following clinical advice to proceed. Senior Conservative figures like Kemi Badenoch urged the government to scrap the trial entirely, calling it “activist ideology masquerading as research”.

Groups such as theBayswater Support Group, which is a British advocacy group for parents who reject their transgender children’s identities, condemned the trial. Keira Bell – who previously took puberty blockers as a teenager but later detransitioned – publicly argued that the trial repeats past errors and fails to safeguard children who cannot give fully informed consent. Harry Potter author JK Rowling has been another major public voice, describing the trial as “an unethical experiment on children who can’t give meaningful consent”.

The Medicines and Healthcare products Regulatory Agency (MHRA) hasnow haltedthe trial warning of unquantified and potentially significant long-term harms. It doesn’t mean the trial has been called off entirely, but officials are demanding immediate discussions with trial leaders at King’s College London. They want the minimum age for participants raising to 14.

Involving 226 children, and funded by the NHS, the trial was set to begin in April this year. As well as the aforementioned reasons for outrage, it was later discovered that participants were offered up to £500 in Love2Shop vouchers (widely-accepted shopping vouchers in the UK) for completing psychometric tests.

MHRA raised concerns about the risk of persistent bone structural changes if the puberty-blocking drugs are taken for more than a year, as well as impacts on brain development, and whether children as young as eight could cope with side effects such as vaginal bleeding. Their stark letter also warned that these drugs are “very likely” to leave children infertile.

Source: SGT Report